Literature DB >> 21293134

Preoperative localisation and surgical management of insulinoma: single centre experience.

Vibha Varma1, Laura Tariciotti, Christopher Coldham, Phillipe Taniere, John A Buckels, Simon R Bramhall.   

Abstract

BACKGROUND: The majority of insulinomas are benign, small and intrapancreatic. Preoperative localisation is important to plan the surgical management.
METHODS: We retrospectively analysed our data on the preoperative imaging, type of surgery and histopathological features of the operated patients with an insulinoma from January 1993 to March 2010. Univariate and multivariate analyses were performed to detect the predictive factors for survival following surgery.
RESULTS: Forty patients were operated on for insulinoma, of which 33 were benign and 7 were malignant. The sensitivity of preoperative computed tomogram scan, magnetic resonance imaging and endoscopic ultrasound, for localising the lesions was 62, 82 and 94%, respectively. Enucleation was performed in 21 (52.5%) patients, and remaining had pancreatic resection. Hepatic resection was performed in 2 and liver transplantation in 1 patient. Morbidity and perioperative mortality was 17 (42.5%) and 1 (2.7%), respectively. The overall 5- and 10-year survival was 89 and 86.5%, respectively. The presence of metastases was found to be an independent predictor of poor survival on multivariate analysis.
CONCLUSION: Preoperative computed tomogram/magnetic resonance imaging and endoscopic ultrasound are sensitive in localizing the majority of insulinomas. Surgery offers a good long-term survival, even in patients with malignant insulinoma.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21293134     DOI: 10.1159/000322405

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  8 in total

Review 1.  Is endoscopic ultrasonography more sensitive than magnetic resonance imaging in detecting and localizing pancreatic neuroendocrine tumors?

Authors:  Peter Herbert Kann
Journal:  Rev Endocr Metab Disord       Date:  2018-06       Impact factor: 6.514

Review 2.  Pancreatic neuroendocrine tumors.

Authors:  Shailesh V Shrikhande; Bhawna Sirohi; Mahesh Goel; Savio G Barreto
Journal:  Indian J Gastroenterol       Date:  2012-10-03

Review 3.  Systematic Review and Metaanalysis of Lymph Node Metastases of Resected Pancreatic Neuroendocrine Tumors.

Authors:  Masayuki Tanaka; Max Heckler; André L Mihaljevic; Pascal Probst; Ulla Klaiber; Ulrike Heger; Simon Schimmack; Markus W Büchler; Thilo Hackert
Journal:  Ann Surg Oncol       Date:  2020-07-27       Impact factor: 5.344

4.  The incidence of insulinoma in Western Sweden between 2002 and 2019.

Authors:  Ellinor Svensson; Andreas Muth; Per Hedenström; Oskar Ragnarsson
Journal:  Ann Gastroenterol       Date:  2022-03-25

5.  Preoperative localization of an insulinoma: selective arterial calcium stimulation test performance.

Authors:  J Morera; A Guillaume; P Courtheoux; L Palazzo; A Rod; M Joubert; Y Reznik
Journal:  J Endocrinol Invest       Date:  2015-11-17       Impact factor: 4.256

6.  CT during celiac artery angiography for localization of clinically suspected small insulinomas.

Authors:  Feng Duan; Yan-Hua Bai; Li Cui; Jie-Yu Yan; Xiao-Hui Li; Xiu-Qi Wang
Journal:  Cancer Imaging       Date:  2018-06-26       Impact factor: 3.909

7.  The role of microwave ablation in management of functioning pancreatic neuroendocrine tumors.

Authors:  Alexey Victorovich Egorov; Ivan Alekseevich Vasilyev; Gaziyav Hadisovich Musayev; Anna Victorovna Mironova
Journal:  Gland Surg       Date:  2019-12

8.  Diagnosis value preoperative localization of insulinoma by diffusion-weighted imaging: A pilot study.

Authors:  Li-Jun Chen; Yue-Dong Han; Ming Zhang
Journal:  Medicine (Baltimore)       Date:  2020-12-04       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.